President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

Health and wellness influencer Janelle Rohner has been using a GLP-1 medication to lose weight. “This isn't easy to say, but ...

Researchers at Karolinska Institutet in Stockholm, Sweden, have shown that specific blood biomarkers can predict development of dementia up to 10 years before symptoms appear. But their primary value ...

Health and wellness influencer Janelle Rohner has received backlash after revealing in a YouTube video posted on April 23 that she’s been taking medication for weight loss.

GLP-1 receptor agonists are effective weight-loss medications, but they may also decrease muscle mass, raising concerns about ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

In this video at Obesity Medicine 2025, Harold E. Bays, MD, FOMA, FTOS, FACC, FASPC, FNLA, discusses highlights from his talk ...

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Defensive lineman Desmond Watson shed 26 pounds in less than a month, but if selected in the NFL draft would still be heaviest player ever picked.

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.